<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[사운드백신 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=43375></link><description><![CDATA[사운드백신 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Fri, 15 May 2026 04:30:05 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2023/06/12_31017998_20230614135552_1688546946.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Sound Vaccine Secures KRW 180,000,000,000 Capital Commitment from GEM as Company Seeks to Get Uplisted on KOSDAQ]]></title><link>https://www.newswire.co.kr/newsRead.php?no=968723</link><description><![CDATA[SEOUL, South Korea--(Business Wire/Korea Newswire)--Sound Vaccine, Inc., (“Sound Vaccine”), a leading manufacturer of advanced hearing medical systems and patented hearing healthcare products, is pleased to announce that it has signed an agreement (“Agreement”) with GEM Global Yield LLC SCS (“GGY”), the Luxembourg-based private alternative investment group, to provide Sound Vaccine with a share s...]]></description><pubDate>Wed, 14 Jun 2023 14:30:00 +0900</pubDate></item><item><title><![CDATA[사운드백신, GEM으로부터 1800억원의 자본금 확보… 코스닥 상장 추진]]></title><link>https://www.newswire.co.kr/newsRead.php?no=968724</link><description><![CDATA[서울--(Business Wire/뉴스와이어)--첨단 청력 의료 시스템 및 특허받은 청력 건강 관리 제품의 선두 제조업체인 사운드백신(Sound Vaccine, Inc., 이하 “사운드백신”)이 룩셈부르크 기반의 사모 대체투자그룹인 GEM 글로벌 일드 LLC SCS(GEM Global Yield LLC SCS, “GGY”)와 2023년 6월 8일 이후 36개월 동안 사운드백신에 최대 1800억원의 주식 청약을 제공하기로 하는 계약(“계약”)을 체결했다고 밝혔다.   ...]]></description><pubDate>Wed, 14 Jun 2023 14:30:00 +0900</pubDate></item></channel></rss>